Nitric oxide mediates the reduced vasoconstrictor response to angiotensin II in patients with preascitic cirrhosis

Journal of Hepatology

Volumn 38, Issue 1, 2003, Pages 44-50

  Helmy, Ahmed ^a   Newby, David Ernest ^a,c   Jalan, Rajiv ^a   Johnston, Neil Russell ^b   Hayes, Peter Clive ^a   Webb, David John ^b  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Forearm blood flow; Human; L NG monomethyl arginine; Nitric oxide clamp; Vascular reactivity

Indexed keywords

ANGIOTENSIN; HYPERTENSIVE AGENT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; BIOSYNTHESIS; BLOOD VESSEL REACTIVITY; CLAMP; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FOREARM BLOOD FLOW; HUMAN; LIVER CIRRHOSIS; LIVER ISCHEMIA; MALE; PATHOGENESIS; PRIORITY JOURNAL; VASOCONSTRICTION; VEIN OCCLUSION PLETHYSMOGRAPHY;

ANGIOTENSIN II; ASCITES; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; FOREARM; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NITRIC OXIDE; OMEGA-N-METHYLARGININE; REGIONAL BLOOD FLOW; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0037235572     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00319-7     Document Type: Article

References (44)

1. Groszmann RJ. Vasodilatation and hyperdynamic circulatory state in chronic liver diseases. In: Bosch J, Groszmann RJ, editors. Portal hypertension. Pathophysiology and treatment, London: Blackwell Scientific, 1994. pp. 17-26.
2. Braillon A, Cales P, Valla D, Gaudy D, Geoffory P, Lebrec D. Influence of the degree of liver failure on the systemic and splanchnic hemodynamics and on the response to propranolol in patients with cirrhosis. Gut 1986;27:1206-1209.
3. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;8:1151-1157.
4. Helmy A, Jalan R, Newby DE, Hayes PC, Webb DJ. Role of angiotensin II in regulation of basal and sympathetically-stimulated vascular tone in patients with early and advanced cirrhosis. Gastroenterology 2000;118:565-572.
5. Helmy A, Jalan R, Newby DE, Johnston NR, Hayes PC, Webb DJ. Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis. Hepatology 2001;33:826-831.
6. Newby DE, Jalan R, Masumori S, Hayes PC, Boon NA, Webb DJ. Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous system. Cardiovasc Res 1998;38:221-228.
7. Castro A, Jimenez W, Claria J, Ros J, Martinez JM, Bosch M, et al. Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide. Hepatology 1993;18:367-372.
8. Hartleb M, Moreau R, Cailmail S, Gaudin C, Lebrec D. Vascular hyporesponsiveness to endothelin-1 in rats with cirrhosis. Gastroenterology 1994;107:1085-1093.
9. Martin P, Gines P, Schrier RW. Nitric oxide as a mediator of hemo-dynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 1998;339:533-541.
10. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989;28:997-1000.
11. Webb DJ. The pharmacology of human blood vessels in vivo. J Vasc Res 1995;32:2-15.
12. Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension 1995;25:918-923.
13. Stroes ESG, Luscher TF, deGroot FG, Koomans HA, Rabelink TJ. Cyclosporin A increases nitric oxide activity in vivo. Hypertension 1997;29:570-575.
14. Verhaar MC, Strachan FE, Newby DE, Cruden NL, Koomans HA, Rabelink TJ, et al. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation 1998;97:752-756.
15. Howes LG, Reid JL. Decreased vascular responsiveness to noradrenaline following regular ethanol consumption. Br J Clin Pharmacol 1985;20:669-674.
16. Hashimoto M, Akishita M, Eto M. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation 1995;92:3431-3435.
17. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989;28:997-1000.
18. Calver A, Harris A, Maxwell JD, Vallance P. Effect of local inhibition of nitric oxide synthesis on forearm blood flow and dorsal hand vein size in patients with alcoholic cirrhosis. Clin Sci 1994;86:203-208.
19. Wiinberg N, Walter-Larsen S, Eriksen C, Nielsen PE. An evaluation of semi-automatic blood pressure manometers against intra-arterial blood pressure. J Arab Monit 1988;1:303-309.
20. Appel PL, Kram HB, Mackabee J, Fleming AW, Shoemaker WC. Comparison of measurements of cardiac output by bioimpedance and thermodilution in severely ill surgical patients. Crit Care Med 1986;14:933-935.
21. Dijkhorst-Oei LT, Stroes ESG, Koomans HA, Rabelink TJ. Acute simultaneous stimulation of nitric oxide and oxygen radicals by angiotensin II in humans in vivo. J Cardiovasc Pharmacol 1999;33:420-424.
22. Morton JJ, Webb DJ. Measurement of plasma angiotensin II. Clin Sci 1985;68:483-484.
23. Haber E, Koerner T, Page LB, Kliman P, Purnode A. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal subjects. J Clin Endocrinol Metab 1969;29:1349-1355.
24. Kerslake DM. The effect of the application of an arterial occlusion cuff to the wrist on the blood flow in the human forearm. J Physiol (Lond) 1949;108:451-457.
25. Hennington BS, Zhang H, Miller T, Granger JP, Reckelhoff JF. Angiotensin II stimulates synthesis of endothelial nitric oxide synthase. Hypertension 1998;31:283-288.
26. Olson SC, Dowds TA, Pino PA, Barry MT, Burke-Wolin T. Angiotensin II stimulates endothelial nitric oxide synthase expression in bovine pulmonary artery endothelium. Am J Physiol 1997;273:L315-L321.
27. 1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery. Hypertension 1995;26:752-757.
28. Wiemer G, Scholkens BA, Wagner A, Heitsch H, Linz W. The possible role of angiotensin II subtype AT2 receptors in endothelial cells and isolated ischemic rat hearts. J Hypertens 1993;11 (Suppl 5):S234-S235.
29. Seyedi N, Xu XB, Najiletti A, Hintze TH. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension 1995;26:164-170.
30. Schroeder ET, Anderson GH, Goldman SH, Streeten DHP. Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis. Kidney Int 1976;9:511-519.
31. Arroyo V, Bosch J, Mauri M, Ribera F, Navarro-Lopez F, Rodés J. Effect of angiotensin-II blockade on systemic and hepatic hemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites. Eur J Clin Invest 1981;11:221-229.
32. Pariente EA, Bataille C, Bercoff E, Lebrec D. Acute effects of captopril on systemic and renal hemodynamics and on renal function in cirrhotic patients with ascites. Gastroenterology 1985;88:1255-1259.
33. Bernardi M, Trevisani F, Santini C, Ligabue A, Capelli M, Gasbarrini G. Impairment of blood pressure control in patients with liver cirrhosis during tilting: study on adrenergic and renin-angiotensin systems. Digestion 1982;25:124-130.
34. Bosch J, Arroyo V, Betriu A, Mas A, Carrilho F, Rivera F, et al. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. Gastroenterology 1980;78:92-99.
35. Gonzalez-Abraldes J, Albillos A, Banares R, Del Arbol LR, Moitinho E, Rodriguez C, et al. Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis. Gastroenterology 2001;121:382-388.
36. Newby DE, Sciberras DG, Mendel CM, Gertz BJ, Boon NA, Webb DJ. Intra-arterial substance P mediated vasodilatation in the human forearm: pharmacology, reproducibility and tolerability. Br J Clin Pharmacol 1997;43:493-499.
37. Ryan J, Jennings G, Dudley F, Chin-Dusting J. Smooth muscle-derived nitric oxide is elevated in isolated forearm veins in human alcoholic cirrhosis. Clin Sci 1996;91:23-28.
38. Campillo B, Chabrier P, Pelle G, Sediame S, Atlan G, Fouet P, et al. Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis. Hepatology 1995;22:1423-1429.
39. Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM. Impaired endothelium-dependent vasodilatation of forearm resistance vessels in hypercholesterolaemia. Lancet 1992;340:1430-1432.
40. Stroes ES, Koomans HA, de Bruin TWA, Rabelink TJ. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet 1995;346:467-471.
41. Lewis FW, Adair O, Rector WG. Arterial vasodilatation is not the cause of increased cardiac output in cirrhosis. Gastroenterology 1992;102:1024-1029.
42. Gentilini P, Romanelli RG, Laffi G, Barletta G, Del Bene R, Messeri G, et al. Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. J Hepatol 1999;30:632-638.
43. Maroto A, Ginès P, Arroyo V, Gines A, Salo J, Claria J, et al. Brachial and femoral artery blood flow in cirrhosis: relationship to kidney dysfunction. Hepatology 1993;17:788-793.
44. Wong F, Liu P, Tobe S, Morali G, Blendis L. Central blood volume in cirrhosis: measurement with radionuclide angiography. Hepatology 1994;19:312-321.